Heron Therapeutics, Inc.
USD0.45
-0.00 (-0.71%)
CEO
Craig Alexander Collard
IPO Date
1987-08-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.48
Prev. Close
$0.45
Day Low
$0.43
Day High
$0.52
52W Low
$0.43
52W High
$2.30
Market Cap
$0.07B
Volume
10.79M
| 125,000 |
| $0.00 |
| 4 May 2026 | Hensley Mark Earl | Chief Operating Officer | M-Exempt | Acquired | 11,770 | $0.00 |
| 4 May 2026 | Hensley Mark Earl | Chief Operating Officer | M-Exempt | Disposed | 11,770 | $0.00 |
| 4 May 2026 | Forbes William P | EVP, Chief Development Officer | M-Exempt | Acquired | 11,694 | $0.00 |
| 4 May 2026 | Forbes William P | EVP, Chief Development Officer | M-Exempt | Acquired | 11,770 | $0.00 |
| 4 May 2026 | Forbes William P | EVP, Chief Development Officer | M-Exempt | Disposed | 11,694 | $0.00 |
| 4 May 2026 | Forbes William P | EVP, Chief Development Officer | M-Exempt | Disposed | 11,770 | $0.00 |
| 4 May 2026 | Duarte Ira | EVP, Chief Financial Officer | M-Exempt | Acquired | 11,694 | $0.00 |
| 4 May 2026 | Duarte Ira | EVP, Chief Financial Officer | M-Exempt | Acquired | 13,535 | $0.00 |